Roche vowing to stay put in Indonesia

29 June 2000

PT Roche Indonesia has said that it will not leave the country even ifit loses its appeal in the Jakarta High Court over a fine of 281 billion ruppiahs ($32.5 million) imposed to compensate a local distributor. Company president Dieter Garbade told the Jakarta Post that Roche's chances of winning in the High Court are very good, and claimed that there was no illegal breach of contract with its distributor PT Perusahaan Dagang Tempo.

Roche came to Indonesia for a long-term business commitment, Mr Garbade added. Despite the fact that the same court last year ordered an injunction to sequester Roche's assets, including a factory and manufacturing equipment, the firm intends to stick to its 1996 plan of expanding its facility in west Java once local economic conditions improve and prices start to pick up.

The sequestration order will take effect if Roche's appeal at the High Court is rejected, the company's lawyer told the newspaper, and the fine is not executable until the final decision on the appeal is made.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight